ArticlePediatric nephrology (Berlin, Germany)2026

Which patients should switch from rituximab to obinutuzumab in refractory nephrotic syndrome?

Shuichiro Fujinaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.